Represented patent owner Polymer Technology Systems, Inc. (“PTS”) as the complainant in a Section 337 investigation in the International Trade Commission. We obtained an initial determination in June 2019 that the Respondents, ACON Laboratories, Inc. and its related entity, infringe two patents, and a further recommendation that the infringing products be banned from importation. On April 16, 2020, the ITC issued a Final Determination finding that ACON Laboratories, Inc. and ACON Biotech (Hangzhou) Co. infringed two of PTS Diagnostics’ key patents. Additionally, the ITC determined that a limited exclusion order prohibiting ACON from importing the infringing products into the U.S. is proper.